STRADA and polyhydramnios, megalencephaly, and symptomatic epilepsy: STRADA is an upstream inhibitor of mTORC1, and individuals with PMSE typically suffer from early-onset intractable epilepsy, neurocognitive delay and MCDs including megalencephaly or cerebral ventriculomegaly.